Whipple Disease — Arthralgia, Malabsorption & PAS-Positive Macrophages

Key Points

• Migratory nonerosive arthralgia can precede GI symptoms by years.
• Classic GI disease causes weight loss, diarrhea, abdominal pain, and malabsorption.
• Duodenal biopsy shows PAS-positive macrophages; organism-specific PCR improves specificity.
• Positive stool or saliva PCR alone does not prove classic disease because asymptomatic carriage occurs.
• CNS and cardiac disease can occur without prominent GI symptoms.
• Antibiotic therapy must provide CNS penetration and continue for a prolonged course.
• Relapse, especially neurologic relapse, can occur after apparently successful treatment.
• Immunosuppression for misdiagnosed inflammatory arthritis can worsen unrecognized Whipple disease.

Algorithm

1. Recognize the pattern of migratory arthralgia followed by weight loss/diarrhea or another compatible systemic syndrome.
2. Obtain CBC, CMP, inflammatory markers, iron/vitamin studies, and targeted cardiac/neurologic evaluation.
3. Perform upper endoscopy with multiple small-bowel biopsies when classic GI disease is suspected.
4. Confirm with T. whipplei PCR on tissue and use sterile-site PCR for atypical focal disease when possible.
5. Evaluate CSF when neurologic involvement is present or strongly suspected.
6. Begin CNS-penetrating IV induction therapy, followed by prolonged oral eradication therapy.
7. Replete nutritional deficits and treat endocarditis/neurologic complications as indicated.
8. Monitor long term for recurrence of GI, joint, cardiac, or neurologic symptoms.

Clinical Synopsis & Reasoning

Whipple disease is a rare chronic systemic infection caused by Tropheryma whipplei. The classic patient has years of intermittent migratory, nonerosive arthralgias before the gastrointestinal phase develops. Later symptoms include weight loss, chronic diarrhea, abdominal pain, steatorrhea, and malabsorption. Lymphadenopathy, hyperpigmentation, fever, anemia, and nutritional deficiencies may occur.

The disease is multisystem. Neurologic involvement can cause cognitive change, supranuclear gaze abnormalities, myoclonus, ataxia, seizures, or hypothalamic dysfunction. Oculomasticatory myorhythmia is a highly specific but rare neurologic sign. Cardiac disease can present as culture-negative endocarditis, sometimes without prominent GI symptoms. Arthritis may dominate the early course and lead to years of rheumatologic treatment before infection is recognized.

Small-bowel biopsy classically shows lamina propria packed with foamy macrophages containing PAS-positive, diastase-resistant material. PCR targeting T. whipplei improves specificity and can be performed on tissue, CSF, synovial fluid, blood, or other specimens depending on the presentation. Because asymptomatic carriage can occur in stool and saliva, a positive nonsterile-site PCR alone does not establish classic Whipple disease.

When classic GI disease is suspected, upper endoscopy with multiple duodenal/jejunal biopsies is high yield. If neurologic symptoms exist, CSF PCR should be considered even when the GI workup is positive because CNS involvement influences treatment strategy and relapse risk. For culture-negative endocarditis, valve tissue PCR can establish the diagnosis.

The reasoning pivot is chronology. Migratory arthralgia that predates malabsorption by years is a major clue. Another important pitfall is starting immunosuppressive therapy for presumed inflammatory arthritis before recognizing an underlying chronic infection, which can worsen disease.

Treatment Strategy & Disposition

Treatment requires prolonged antibiotics with reliable CNS penetration because relapse may occur from occult neurologic infection. Common regimens begin with an induction phase using IV ceftriaxone or a penicillin-based regimen for roughly 2–4 weeks, followed by prolonged oral therapy. Traditional regimens have used trimethoprim-sulfamethoxazole for 1–2 years, while other expert approaches use doxycycline plus hydroxychloroquine for extended therapy. Exact regimen should follow current infectious-disease guidance, CNS involvement, susceptibility considerations, and patient factors.

Patients often improve clinically within weeks, but relapse can occur months or years later. Neurologic relapse is particularly concerning and can be difficult to treat. Follow-up should track weight, GI symptoms, anemia, nutritional deficits, neurologic findings, and the original manifestation such as arthritis or endocarditis. Repeat biopsy or PCR is individualized rather than performed reflexively in every asymptomatic patient.

Supportive care includes nutritional repletion, treatment of anemia and vitamin deficiencies, and management of cardiac or neurologic complications. Culture-negative endocarditis requires standard endocarditis assessment in addition to organism-directed antibiotics, including evaluation for valve dysfunction or surgical indications.

An immune reconstitution-like inflammatory syndrome can occur after therapy begins, with fever or inflammatory symptoms despite microbiologic treatment. This should be distinguished from relapse, drug reaction, and untreated complications. Severe neurologic disease, endocarditis, major malnutrition, or inability to tolerate therapy generally warrants inpatient or specialist care.

Epidemiology / Risk Factors

• Whipple disease is rare despite T. whipplei carriage being more common than clinical disease.
• It classically affects middle-aged adults and has historically been reported more often in men.
• Occupational/environmental exposure patterns suggest fecal-oral acquisition, but pathogenesis depends strongly on host susceptibility.
• Delayed diagnosis is common because early joint symptoms mimic inflammatory rheumatic disease.

Investigations

Whipple Disease Presentations

Pharmacology

Prognosis / Complications

• Most patients improve markedly with appropriate prolonged antibiotics.
• Untreated disease is progressive and potentially fatal.
• Neurologic relapse can cause permanent disability.
• Long-term follow-up is warranted even after apparent remission.

Patient Education / Counseling

• Explain why prolonged antibiotics are needed even after GI symptoms improve.
• Review signs of relapse, especially new cognitive, visual, gait, or movement abnormalities.
• Discuss medication adherence and toxicity monitoring for long courses.
• Warn against restarting immunosuppressive arthritis treatment without reassessing for active infection.
• Encourage nutritional follow-up until weight and deficiencies normalize.

Notes

Whipple disease is a chronology-driven diagnosis. The patient may first enter medical care through rheumatology for migratory arthralgias and only years later develop diarrhea and weight loss. Recognizing that sequence prevents the infection from being fragmented into separate diagnoses.

The second key concept is specimen quality. T. whipplei can be carried without invasive disease, so PCR from stool or saliva is less persuasive than PCR from involved tissue or a sterile site. The diagnostic standard is therefore clinicopathologic coherence: compatible syndrome, characteristic tissue findings, and organism-specific confirmation.

References

1. Clinical Manifestations, Treatment, and Diagnosis of Tropheryma whipplei Infections — Link
2. Mayo Clinic — Whipple disease diagnosis and treatment — Link